GOLD 2025 Report: Lung Microbiome and Chest CT Imaging in COPD

Author(s):

M. Bradley Drummond, MD, MHS,MeiLan K. Han, MD, MS

Panelists discuss how dysbiosis of the lung microbiome can exacerbate chronic obstructive pulmonary disease (COPD) through increased inflammation and altered immune responses. In contrast, chest CT imaging is indicated for patients with severe COPD, suspected comorbidities, surgical planning, or unexplained symptoms despite standard treatment. These factors highlight the complexity of COPD management.

EP: 1.Overview and Diagnosis of COPD

EP: 2.Risk Factors for COPD

EP: 3.Mortality and Comorbidities with COPD

EP: 4.Health and Economic Burden of COPD

EP: 5.Treatment of COPD Based on Symptoms

EP: 6.GOLD 2025 Report: Prebronchodilator Spirometry and Diagnosis of COPD

Now Viewing

EP: 7.GOLD 2025 Report: Lung Microbiome and Chest CT Imaging in COPD

Video content above is prompted by the following:

How can dysbiosis in the lung microbiome contribute to the development and progression of COPD?
Chest CT imaging should be considered in which patient populations with COPD?